Items Tagged ‘FLT3’

December 15th, 2015

Midostaurin Improves Survival in Subset of Acute Myeloid Leukemia


The targeted agent, midostaurin, has demonstrated a survival improvement among patients with acute myeloid leukemia (AML) that has the TMS-like tyrosine kinase 3 (FLT3) mutation. These results were presented at a plenary session at the 2015 annual meeting of the American Society of Hematology (ASH), in Orlando, Florida. Acute myeloid leukemia is a type of […]

View full entry

Tags: Acute Myeloid Leukemia, FLT3, Leukemia, midostaurin, myeloid leukemia, News, targeted agent